All Search Results

Thousands of chemical hair straightener lawsuits have been filed and are still pending. The plaintiffs allege that they developed uterine cancer, endometrial cancer, or ovarian cancer after using hair straighteners with potentially dangerous ingredients that the manufacturers failed to properly warn about.

Thousands of people have filed lawsuits against weight loss drug manufacturers Novo Nordisk and Eli Lilly. The lawsuits claim drugs like Ozempic®, Wegovy® and Mounjaro® caused extreme and unadvertised side effects. These lawsuits are currently proceeding in federal and state courts and may lead to settlements or…

Zepbound is the brand name for the injectable prescription medication tirzepatide, a dual agonist drug that helps with weight management. Zepbound users have reported serious gastrointestinal issues, including gastroparesis and gastroenteritis. A Zepbound lawsuit filed against manufacturer Eli Lilly could help…

Studies have established a link between the use of hair straightener chemical products and an increased risk of ovarian, uterine and endometrial cancers. This risk may be greater for Black women. If you’ve been diagnosed with these cancers you may be able to file a lawsuit for the elevated cancer risk that some…

Strength of Nature Global, LLC faces lawsuits for its “Just for Me” hair relaxer product. Just for Me is a chemical hair straightener marketed specifically for children. Although Just for Me is marketed as safe to use, it contains harmful chemicals that can harm the endocrine system and cause cancer.

An olive oil relaxer lawsuit has been filed against Namaste LLC. The lawsuit claims the company falsely marketed ORS Olive Oil hair relaxer as containing all natural ingredients. However, the product’s chemicals are allegedly unsafe and may increase the risk of ovarian and uterine cancer.

Which hair relaxers may cause cancer is becoming a widespread concern. Manufacturers like L’Oréal, SoftSheen-Carson, Revlon and others currently face lawsuits. These lawsuits claim the companies failed to warn of and didn’t disclose certain harms to product users. Health conditions associated with the toxic chemicals…

Ozempic® is a GLP-1 agonist drug intended to treat diabetes. It is also used off-label for weight loss. However, many expected and unexpected side effects are associated with using Ozempic. These risks can vary in severity, from severe vision loss and blindness to intestinal blockages and many other serious health…

There are established connections between some prescription and over-the-counter (OTC) medications and birth defects. If a pregnant woman takes these medications, her child may be born with a birth defect that can impact the child’s quality of life. Families who experienced this situation may be eligible to file a…

People taking Ozempic to manage type 2 diabetes or weight loss risk developing non-arteritic anterior ischemic optic neuropathy (NAION). This is a rare eye condition that can lead to Ozempic-related blindness. Recent research has linked NAION to semaglutide (the active ingredient in Ozempic and Wegovy).

Aircraft in South Korea, Canada, and Norway each experienced crash landings beginning on the evening of December 28 and into the morning of December 29.

Saxenda (liraglutide) is a weight-loss drug. It is in the same class of drugs (GLP-1s) as well-known diabetes medications like Ozempic and Mounjaro. It has been linked to serious side effects that are not listed on the manufacturer’s label. People are filing Saxenda lawsuits due to these injuries. The cases are being…

Trulicity® (dulaglutide) lawsuits claim that drug manufacturer Eli Lilly knew or should have known that its product may cause serious health problems but failed to warn consumers about dangerous side effects. Plaintiffs are seeking compensation for injuries related to taking Trulicity, such as gastroparesis and…

Tirzepatide deaths can result from drug complications, including serious stomach problems, gallbladder problems, kidney failure, pancreatitis and thyroid cancer. Tirzepatide is the active ingredient in Mounjaro® and Zepbound®. Eli Lilly manufactures and sells these two popular medications.

Zepbound (tirzepatide) is the first tirzepatide medication specifically approved for weight loss. Like all medications, Zepbound has side effects and adverse reactions ranging from mild to severe. When serious side effects aren’t listed in the prescribing documents, doctors and patients are in the dark. They can only…

Breast implants side effects involve serious health conditions, including breast implant-associated anaplastic large cell lymphoma (BIA-ALCL), a rare cancer affecting the immune system. Other potential breast implant risks include breast pain, bruising, change in nipple sensation, disfigurement, fatigue, scarring,…

During pregnancy, mothers-to-be run the risk of exposure to medicines, chemicals and environmental contaminants that can result in birth defects. Birth defect lawsuits may help parents receive money as compensation for injury to provide their affected children with proper care.

If you were diagnosed with a neurological condition after exposure to paraquat, you may be eligible to file a lawsuit to seek compensation. If your case results in a settlement, it could reimburse lost wages, cover pain and suffering and help you manage medical expenses. A lawsuit and potential paraquat settlement…

The FDA has linked some types of textured breast implants to a rare lymphatic cancer called breast implant-associated anaplastic large cell lymphoma (BIA-ALCL). According to lawsuits, implant manufacturers knew about this increased cancer risk for many years but didn’t properly warn consumers.

The U.S. Securities and Exchange Commission (SEC) has granted an award of more than $6 million to two whistleblowers represented by Motley Rice LLC for the pair’s role in safeguarding investors and upholding market integrity.